A Feasibility Study of MR-based target delineation for Radiotherapy Treatment planning For Gastric Cancer

A Feasibility Study of MR-based target delineation for Radiotherapy Treatment planning For Gastric Cancer - MRI in gastric cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON43148

Enrollment

Registered

2016-08-31

Start date

2016-12-22

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

The patients will undergo MRI exams at two time points, before and after (partial) gastrectomy. The scan duration of the first exam is approximately 50 minutes and the second scan will be less. The

Gastric cancer

Radiotherapy

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: Patients with histologically proven gastric cancer, receiving a (partial) gastrectomy

Exclusion criteria

Exclusion criteria: * Contra*indications for a MRI exam. * Patients with prior irradiation or surgery in the gastric area. * Patients with WHO performance status > 2.

Design outcomes

Secondary

Measure	Time frame
Secondary endpoints (part 2) * Volumetric differences between clinical target volumes before (first MRI) and after (partial) gastrectomy (second MRI) * Software tool for an MR-based target delineation for the treatment planning of the stomach * Definition and delineation of the Gross Tumour Volume (GTV)	—

Primary

Measure	Time frame
Primary endpoints (part 1) * Definition and delineation of the Clinical Target Volume (CTV) and Organs-At-Risk * Assessment of the time-averaged mid-position	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)